Medical devices tenders in Montenegro.

The market recorded around 150 medical device tenders in the latest 120 days, up 10% from the preceding period. That equals roughly 37 opportunities per month or 9 per week. Activity accelerated sharply in April, then cooled through July, so suppliers should expect an uneven flow.

Announced value totals EUR 13.8M. The average award is EUR 93K, while the median is EUR 25K, showing a long tailed market. A small number of large procurements lifts the average, so suppliers should use the median as a better guide to typical opportunity size.

Demand is concentrated among major clinical institutions. The leading clinical centre accounts for EUR 6.7M, while a national transfusion institute and hospitals also appear among important buyers. Around 30 organisations were active, but a handful of leading buyers represented 87% of disclosed value, making institutional access essential.

The median bid window is 15 days. Because this is a median, some notices will allow less or more time. Suppliers should maintain current product, compliance, pricing, and delivery documents, then review each notice immediately and reserve time for clarification, submission, and any required tender formalities.

Foreign suppliers should first confirm the portal’s eligibility, documentation, language, delivery, and representation requirements for each notice. The market data shows concentrated institutional demand, so a targeted local access strategy may be more practical than broad coverage. The official notice remains the source for binding requirements and deadlines.

Yes, the market appears comparatively accessible to new entrants: 53% of winning companies took exactly one contract during the period. That does not guarantee success, because several large awards dominate value. A newcomer should qualify carefully, meet every requirement, and target suitable episodic opportunities rather than chase volume.

Medical device opportunities are published on the official national procurement portal. They fall within CPV division 33, which can help suppliers locate relevant notices. However, suppliers should read the complete notice and tender documents, since the classification alone will not capture every eligibility, technical, commercial, or submission requirement.

Competition is mixed. The number of winning companies is smaller than the opportunity flow, yet 53% of winners secured only one contract, suggesting room for capable suppliers. At the same time, a few high value awards skew results, while buyer concentration means relationships and access to leading institutions matter greatly.

Start with CPV division 33, then screen by buyer, clinical relevance, estimated value, and deadline. Prioritize notices from leading clinical institutions and assess whether the requirement matches your products and evidence. Given the 15 day median window, saved searches and daily review are more useful than occasional broad browsing.

Otnox helps turn the market signals into a focused workflow: monitor medical device notices, identify priority buyers, compare opportunity value with the EUR 25K median, and flag deadlines around the 15 day median window. This supports selective qualification for high value episodic tenders instead of unfocused volume chasing.